Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …
HSP90 inhibitors and cancer: Prospects for use in targeted therapies
ZN Li, Y Luo - Oncology reports, 2022 - spandidos-publications.com
Heat shock protein 90 (HSP90) is a vital chaperone protein, regulating signaling pathways
and correcting misfolded proteins in cancer cells by interacting with oncogenic client …
and correcting misfolded proteins in cancer cells by interacting with oncogenic client …
Targeting heat shock proteins in cancer: a promising therapeutic approach
S Chatterjee, TF Burns - International journal of molecular sciences, 2017 - mdpi.com
Heat shock proteins (HSPs) are a large family of chaperones that are involved in protein
folding and maturation of a variety of “client” proteins protecting them from degradation …
folding and maturation of a variety of “client” proteins protecting them from degradation …
[Retracted] Apoptosis and Molecular Targeting Therapy in Cancer
M Hassan, H Watari, A AbuAlmaaty… - BioMed research …, 2014 - Wiley Online Library
Apoptosis is the programmed cell death which maintains the healthy survival/death balance
in metazoan cells. Defect in apoptosis can cause cancer or autoimmunity, while enhanced …
in metazoan cells. Defect in apoptosis can cause cancer or autoimmunity, while enhanced …
Biophysics in drug discovery: impact, challenges and opportunities
JP Renaud, C Chung, UH Danielson, U Egner… - Nature reviews Drug …, 2016 - nature.com
Over the past 25 years, biophysical technologies such as X-ray crystallography, nuclear
magnetic resonance spectroscopy, surface plasmon resonance spectroscopy and …
magnetic resonance spectroscopy, surface plasmon resonance spectroscopy and …
[HTML][HTML] Discovery of small molecule cancer drugs: successes, challenges and opportunities
The discovery and development of small molecule cancer drugs has been revolutionised
over the last decade. Most notably, we have moved from a one-size-fits-all approach that …
over the last decade. Most notably, we have moved from a one-size-fits-all approach that …
Old and new approaches to target the Hsp90 chaperone
J Sanchez, TR Carter, MS Cohen… - Current cancer drug …, 2020 - ingentaconnect.com
The 90-kDa heat shock protein (Hsp90) is a molecular chaperone that ensures cellular
proteostasis by maintaining the folding, stabilization, activation, and degradation of over 400 …
proteostasis by maintaining the folding, stabilization, activation, and degradation of over 400 …
Heat shock protein 90 inhibitors: an update on achievements, challenges, and future directions
L Li, L Wang, QD You, XL Xu - Journal of medicinal chemistry, 2019 - ACS Publications
Hsp90 is one of the most important chaperones involved in regulating the maturation of
more than 300 client proteins, many of which are closely associated with refractory diseases …
more than 300 client proteins, many of which are closely associated with refractory diseases …
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4 …
HJ Tseng, S Banerjee, B Qian, MJ Lai, TY Wu… - European Journal of …, 2023 - Elsevier
Abstract Monoamine oxidase A (MAO A) and heat shock protein 90 (HSP90) inhibitors have
been shown to decrease the progression of glioblastoma (GBM) and other cancers. In this …
been shown to decrease the progression of glioblastoma (GBM) and other cancers. In this …
POVME 3.0: software for mapping binding pocket flexibility
JR Wagner, J Sørensen, N Hensley… - Journal of chemical …, 2017 - ACS Publications
We present a substantial update to the open-source POVME binding pocket analysis
software. New capabilities of POVME 3.0 include a flexible chemical coloring scheme for …
software. New capabilities of POVME 3.0 include a flexible chemical coloring scheme for …